Correlation Between Eterna Therapeutics and Rxsight

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Rxsight at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Rxsight into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eterna Therapeutics and Rxsight, you can compare the effects of market volatilities on Eterna Therapeutics and Rxsight and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Rxsight. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Rxsight.

Diversification Opportunities for Eterna Therapeutics and Rxsight

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Eterna and Rxsight is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Rxsight in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rxsight and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Rxsight. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rxsight has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Rxsight go up and down completely randomly.

Pair Corralation between Eterna Therapeutics and Rxsight

Given the investment horizon of 90 days Eterna Therapeutics is expected to generate 5.62 times more return on investment than Rxsight. However, Eterna Therapeutics is 5.62 times more volatile than Rxsight. It trades about 0.09 of its potential returns per unit of risk. Rxsight is currently generating about -0.03 per unit of risk. If you would invest  32.00  in Eterna Therapeutics on November 9, 2024 and sell it today you would earn a total of  2.00  from holding Eterna Therapeutics or generate 6.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Eterna Therapeutics  vs.  Rxsight

 Performance 
       Timeline  
Eterna Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Eterna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Rxsight 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Rxsight has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Eterna Therapeutics and Rxsight Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eterna Therapeutics and Rxsight

The main advantage of trading using opposite Eterna Therapeutics and Rxsight positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Rxsight can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rxsight will offset losses from the drop in Rxsight's long position.
The idea behind Eterna Therapeutics and Rxsight pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Fundamental Analysis
View fundamental data based on most recent published financial statements
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device